Project Description

Visit Website

Jvion delivers healthcare’s only Cognitive Clinical Success Machine. Using Eigen-based technology, the machine does what simple predictive analytics or machine learning models cannot. It goes beyond high-risk patient populations to identify those on a trajectory to becoming high risk.

It determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive action across hospitals, populations, and patients.

FUND: HEP III

STATUS: Private

Jay Deady, CEO, is a visionary and innovator with 30 years of healthcare experience leading both private and publicly traded companies. Jay’s most recent role was as CEO of Recondo, a leading AI revenue cycle company, where he and the team focused on growth and product innovation that ultimately moved Recondo from last to first in KLAS client satisfaction. Recondo was acquired by Waystar in December 2019. Prior to Recondo, Jay served as CEO of Awarepoint, a clinical technology and software company, where he grew the company into the leading technology provider in the caregiver and patient asset-flow and capacity-management market. Prior to Awarepoint, Jay held leadership positions at Eclipsys (now Allscripts), McKesson Provider Technologies, Cerner Corporation and ADAC Healthcare.

Jay holds a Bachelor of Arts from Tufts University, is a graduate of the Global Executive Management program of the Wharton School of Business at the University of Pennsylvania, as well as multiple certifications in Total Quality Management.